Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.

Wang, Yuelong; Deng, Jiaojiao; Guo, Gang; Tong, Aiping; Peng, Xirui; Chen, Haifeng; Xu, Jianguo; Liu, Yi; You, Chao; Zhou, Liangxue

Wang, Yuelong; Deng, Jiaojiao; Guo, Gang; Tong, Aiping; Peng, Xirui; Chen, Haifeng; Xu, Jianguo; Liu, Yi; You, Chao; Zhou, Liangxue.

Afiliación

Wang Y; West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, People's Republic of China.
Deng J; West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, People's Republic of China.
Guo G; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, People's Republic of China.
Tong A; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, People's Republic of China. aipingtong@scu.edu.cn.
Peng X; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, People's Republic of China.
Chen H; West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, People's Republic of China.
Xu J; West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, People's Republic of China.
Liu Y; West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, People's Republic of China.
You C; West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, People's Republic of China.
Zhou L; West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, People's Republic of China. liangxue_zhou@126.com.

J Neurooncol ; 131(1): 21-29, 2017 01.

Article en En | MEDLINE | ID: mdl-27640198

Asunto(s)

Anexina A2/metabolismo; Encéfalo/metabolismo; Craneofaringioma/metabolismo; Neoplasias Hipofisarias/metabolismo; Adolescente; Adulto; Anciano; Anexina A2/genética; Antineoplásicos/farmacología; Movimiento Celular/efectos de los fármacos; Movimiento Celular/fisiología; Proliferación Celular/efectos de los fármacos; Proliferación Celular/fisiología; Niño; Preescolar; Estudios de Cohortes; Craneofaringioma/patología; Craneofaringioma/fisiopatología; Receptores ErbB/metabolismo; Femenino; Gefitinib; Regulación Neoplásica de la Expresión Génica/efectos de los fármacos; Regulación Neoplásica de la Expresión Génica/fisiología; Humanos; Masculino; Persona de Mediana Edad; Proteína Oncogénica v-akt/metabolismo; Neoplasias Hipofisarias/patología; Neoplasias Hipofisarias/fisiopatología; Pronóstico; Quinazolinas/farmacología; Transducción de Señal/efectos de los fármacos; Células Tumorales Cultivadas/efectos de los fármacos; Adulto Joven

Palabras clave

Adamantinomatous craniopharyngioma; Annexin A2; Gefitinib resistance; Proliferation; Recurrence

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Hipofisarias / Encéfalo / Anexina A2 / Craneofaringioma Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google